NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-153-2016-0-GB-14 ANTI-KK-LC-1 T CELL RECEPTORS GB EP 17733120.4 Issued
NCI E-153-2016-0-DK-10 ANTI-KK-LC-1 T CELL RECEPTORS DK EP 17733120.4 Issued
NCI E-153-2016-0-NO-18 ANTI-KK-LC-1 T CELL RECEPTORS NO EP 17733120.4 Issued
NCI E-153-2016-0-ES-11 ANTI-KK-LC-1 T CELL RECEPTORS ES EP 17733120.4 Issued
NCI E-153-2016-0-SE-19 ANTI-KK-LC-1 T CELL RECEPTORS SE EP 17733120.4 Issued
NCI E-153-2016-0-EP-05 ANTI-KK-LC-1 T CELL RECEPTORS EP National Stage 17733120.4 Issued
NCI E-153-2016-0-BE-07 ANTI-KK-LC-1 T CELL RECEPTORS BE EP 17733120.4 Issued
NCI E-153-2016-0-DE-09 ANTI-KK-LC-1 T CELL RECEPTORS DE EP 17733120.4 Issued
NCI E-153-2016-0-FR-13 ANTI-KK-LC-1 T CELL RECEPTORS FR EP 17733120.4 Issued
NCI E-153-2016-0-FI-12 ANTI-KK-LC-1 T CELL RECEPTORS FI EP 17733120.4 Issued
NIDDK E-138-2017-0-US-11 Compounds And Methods For Treating Brain Injury US National Stage 16/095,282 Pending
NIAID E-154-2010-1-EP-05 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines EP DIV 18201391.2 Pending
NCI E-153-2016-0-AU-03 ANTI-KK-LC-1 T CELL RECEPTORS AU National Stage 2017258745 Pending
NCI E-014-2018-0-US-03 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development US ORD 16/161,542 10543263 Issued PDF
NIAID E-240-2017-0-PCT-03 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE PCT PCT PCT/US2018/056135 Expired
NCI E-014-2018-0-CN-08 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development CN National Stage 201880080739.4 Pending
NIAID E-240-2017-0-EP-04 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE EP National Stage 18808145.9 Pending
NCI E-014-2018-0-JP-05 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development JP National Stage 2020-521362 Pending
NCI E-014-2018-0-CA-06 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development CA National Stage 3078962 Pending
NCI E-014-2018-0-AU-04 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development AU National Stage 2018352245 Pending
NCI E-014-2018-0-PCT-02 Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development PCT PCT PCT/US2018/056011 Expired
NCI E-059-2013-0-RU-11 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor RU DIV 2018136226 Issued
NCI E-116-2014-0-US-05 IODONIUM ANALOGS AS INHIBITORS OF NADPH OXIDASES AND OTHER FLAVIN DEHYDROGENASES; FORMULATIONS THEREOF; AND USES THEREOF US CON 16/160,599 10738047 Issued PDF
NCI E-097-2017-0-PCT-02 Macromolecular Platform For Targeting Scavenger Receptor A1 PCT PCT PCT/US2018/055794 Expired
NCI E-097-2017-0-EP-06 Macromolecular Platform For Targeting Scavenger Receptor A1 EP National Stage 18867617.5 Pending
NCI E-097-2017-0-AU-03 Macromolecular Platform For Targeting Scavenger Receptor A1 AU National Stage 2018350825 Pending
NCI E-097-2017-0-CA-04 Macromolecular Platform For Targeting Scavenger Receptor A1 CA National Stage 3079121 Pending
NINDS E-146-2016-1-US-03 SELECTIVE D3 DOPAMINE RECEPTOR AGONISTS AND METHODS OF THEIR USE US National Stage 16/093,365 11634404 Issued PDF
CC E-184-2012-0-JP-01 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging JP DIV 2020-031965 Issued
CC E-184-2012-0-JP-10 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging JP DIV 2018-193368 Issued
NHLBI E-183-2018-0-PCT-02 3D Bioprinting Of Cardiac Patch With Anisotropic And Perfusable Architecture PCT PCT PCT/US2018/055707 Expired
NCI E-265-2011-0-CN-24 Anti-CD22 Chimeric Antigen Receptors CN DIV 201811193712.4 Issued
NCI E-131-2016-0-EP-05 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO EP National Stage 17724960.4 Issued
NCI E-131-2016-0-ES-10 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO ES EP 17724960.4 Issued
NCI E-131-2016-0-FR-11 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO FR EP 17724960.4 Issued
NCI E-131-2016-0-DE-09 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO DE EP 17724960.4 Issued
NCI E-131-2016-0-IT-13 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO IT EP 17724960.4 Issued
NCI E-131-2016-0-CH-08 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO CH EP 17724960.4 Issued
NCI E-131-2016-0-GB-12 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO GB EP 17724960.4 Issued
NCATS E-115-2018-2-US-02 EMETINE COMPOUNDS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US ORD 16/156,124 10555942 Issued PDF
NIAID E-118-2016-0-KR-11 Live Attenuated Zika Virus Vaccine KR National Stage 10-2018-7029244 Abandoned
NCI E-002-2018-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING P38 MAPK INHIBITORS PCT PCT PCT/US2018/055206 Expired
NCATS E-115-2018-2-PCT-01 EMETINE COMPOUNDS AND COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION PCT PCT COMB PCT/US2018/055147 Expired
NIAID E-021-2019-0-US-07 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US CON 16/155,857 Abandoned
NIDDK E-138-2017-0-EP-06 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS EP National Stage 17786774.4 Pending
NCI E-266-2011-0-CN-14 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage CN DIV 201811170958.X Issued
NIAID E-102-2016-0-EP-03 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE EP National Stage 17712642.2 Issued
NCI E-131-2016-0-AU-03 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO AU National Stage 2017254645 Issued
NIAID E-142-2016-0-US-04 FRANCISELLA LIPIDS AS BROAD ANTI-INFLAMMATORY THERAPEUTICS AND ASSOCIATED METHODS OF USE US National Stage 16/091,768 11529312 Issued PDF
NCATS E-240-2011-0-US-04 Human Galactokinase Inhibitors For The Treatment Of Galactosemia And Cancers US CON 16/152,735 10471061 Issued PDF